Form 4 for PMVP PMV Pharmaceuticals, Inc.
Accepted 2022-09-13 00:00:00 ET · period of report 2022-09-09 · accession 0001209191-22-049692 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-13 | 2022-09-09 | PMVP | Alland Leila | Chief Medical Off | A - Grant | $0.00 | +52.2K | 52.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-09 | A | A | 52,200 | $0.00 | 52,200 | D | — | — | (F1) The reported shares are represented by restricted stock units, or RSUS. One- third of the RSUs vest on September 9, 2023 and the remaining shares vest on September 9, 2024. |